Photo of Martijn Meijerink from vumc.nl
Jun 4, 2024, 04:06
Jun Gong: Dr. Martijn Meijerink’s Phase III COLLISION trial less than 10 colorectal liver metastases
Jun Gong, Medical oncologist and researcher in gastrointestinal and genitourinary cancers at Cedars-Sinai, shared a post on X:
“Dr. Meijerink Phase III COLLISION trial less than 10 colorectal liver metastases (CRLMs) 1:1 resection versus ablation showed similar overall survival (OS), not different in local and distant recurrence.
Both arms got 20-23% chemotherapy, mean tumor size < 20 mm, low tumor burden.”
Source: Jun Gong/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 20:58
Aug 25, 2025, 20:44
Aug 25, 2025, 20:33
Aug 25, 2025, 19:54
Aug 25, 2025, 19:00
Aug 25, 2025, 17:36